慢阻肺住院后第一年再入院与死亡的风险轨迹
该研究基于美国联邦医疗保险(Medicare)65岁及以上受益人数据,分析慢阻肺(COPD)出院后1年内每日再入院与死亡的绝对风险,并按呼吸机支持方式分层。结果显示1年再入院率为64.2%,死亡率为26.2%,且再入院与死亡风险随通气支持需求不同而持续较长时间,提示仅限出院后第一个月的干预可能不足以改善长期结局。
要点
- COPD出院后1年再入院率64.2%,死亡率26.2%。
- 有创通气者死亡风险下降50%需3天,无通气者需17天。
- 再入院风险下降50%需28至43天,平台期可达61天。
核心结论
- COPD出院后再入院与死亡风险持续较长时间,且随通气支持需求不同而变化。
- 仅限出院后第一个月的干预可能不足以改善长期结局。
研究设计与样本
- 基于Medicare 65岁及以上受益人COPD出院后数据的回顾性队列分析。
- 计算出院后1年内每日再入院与死亡的绝对风险,并按有创通气、无创通气、无通气分层。
- 再入院分析纳入2,340,637例住院,死亡分析纳入1,283,069例住院。
主要发现
- 1年再入院率为64.2%,有创通气、无创通气、无通气组分别为63.5%、66.0%、64.1%。
- 1年死亡率为26.2%,有创通气、无创通气、无通气组分别为45.7%、41.8%、24.4%。
- 再入院日风险下降50%所需时间分别为有创28天、无创39天、无通气43天,平台期分别为46、54、61天。
- 死亡日风险下降50%所需时间分别为有创3天、无创4天、无通气17天,平台期分别为21、18、24天。
- COPD出院后住院和死亡风险显著高于一般Medicare人群。
临床怎么用
- 出院后风险轨迹因通气支持需求不同而异,应据此制定随访与干预计划。
- 干预窗口不应仅限于出院后第一个月,需覆盖风险持续期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Characterization of the dynamic nature of posthospital risk in chronic obstructive pulmonary disease (COPD) is needed to provide counseling and plan clinical services. OBJECTIVES: To analyze risk of readmission and death after discharge for COPD among Medicare beneficiaries aged 65 years and older and to determine the association between ventilator support and risk trajectory. METHODS: We computed daily absolute risks of hospital readmission and death for 1 year after discharge for COPD, stratified by ventilator support. We determined the time required for risks to decline by 50% from maximum daily values after discharge and for daily risks to plateau. We compared risks with those found in the general elderly population. MEASUREMENTS AND MAIN RESULTS: Among 2,340,637 hospitalizations, the readmission rate at 1 year was 64.2%, including 63.5%, 66.0%, and 64.1% among those receiving invasive, noninvasive, and no ventilation, respectively. Among 1,283,069 hospitalizations, mortality at 1 year was 26.2%, including 45.7%, 41.8%, and 24.4% among those same respective groups. Daily risk of readmission declined by 50% within 28, 39, and 43 days and plateaued at 46, 54, and 61 days among those receiving invasive, noninvasive, and no ventilation, respectively. Risk of death declined by 50% by 3, 4, and 17 days and plateaued by 21, 18, and 24 days in the same respective groups. Risks of hospitalization and death were significantly higher after discharge for COPD than among the general Medicare population. CONCLUSIONS: Discharge from the hospital is associated with prolonged risks of readmission and death that vary with need for ventilator support. Interventions limited to the first month after discharge may be insufficient to improve longitudinal outcomes.
引用
- Lindenauer PK, Dharmarajan K, Qin L, et al. Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018. PMID: 29206052. doi:10.1164/rccm.201709-1852OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。